IP Library Granted Patent US 9,381,155
Granted Patent B2
US 9,381,155 · App. 14/498,447 · Granted Jul 5, 2016

Process for manufacturing chewable dosage forms for drug delivery and products thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,381,155
App. No.
14/498,447
Granted
Jul 5, 2016
Kind
B2
Abstract

A palatable, edible soft chewable medication vehicle for delivery of a pharmaceutically acceptable active ingredient, such as a drug, to an animal or human subject. The edible soft chews contain only food grade or better inactive ingredients, and preferably do not contain ingredients of animal origin. Processes for manufacturing the edible soft chews do not require the use of heat or the addition of water during mixing of active and inactive ingredients, provide stable concentrations of the active ingredient, and produce chews of consistent weight and texture.

Claims (27)

1. A process for manufacturing an edible soft chewable medication (a “soft chew”) having consistent unit-to-unit weight and active ingredient content, the process comprising:

(a) mixing at least one active ingredient with an oil;

(b) blending the mixture comprising the at least one active ingredient and oil formed in step (a) with dry inactive ingredients comprising at least one of each of a flavoring, a binder, a bulking agent, a humectant, and an excipient in a mixer having a mixing chamber and mixing shaft, wherein operation of the mixer causes a soft chew mixture to be formed having the active ingredient uniformly blended therein, and wherein the soft chew mixture and the ingredients thereof are maintained at room temperature or +/−10° C. thereof during blending;

(c) adding an anti-sticking agent to the mixture of step (b) and blending to form a soft chewable mixture; and

(d) forming the soft chewable mixture into individual soft chews without use of extrusion.

2. The process of claim 1 , wherein the excipient comprises a starch, a cellulose, crospovidone, derivatives thereof, or a mixture thereof.

3. The process of claim 1 , wherein the excipient is selected from the group consisting of sodium starch glycolate, pregelatinized corn starch, crospovidone, and croscarmellose sodium.

4. The process of claim 1 , wherein the excipient is selected from the group consisting of sodium starch glycolate, crospovidone, and croscarmellose sodium.

5. The process of claim 1 , wherein the soft chew comprises starch.

6. The process of claim 5 , wherein starch constitutes from about 15% to about 50% by weight of the soft chew.

7. The process of claim 6 , wherein the anti-sticking agent constitutes from about 1 to 3 percent (w/w) of the edible soft chewable medication.

8. The process of claim 7 , wherein the anti-sticking agent comprises polyethylene glycol.

9. The process of claim 1 , wherein the active ingredient is selected from the group consisting of an anthelmetic, an analgesic, an antibiotic, an antiviral, an anti-inflammatory, an endoparasiticide, an ectoparasiticide, an antifungal, and combinations thereof.

10. The process of claim 9 , wherein the active ingredient is coated.

11. The process of claim 6 , wherein the oil comprises soybean oil.

12. The process of claim 11 , wherein the humectant is selected from the group consisting of glycerol and propylene glycol.

13. The process of claim 11 , wherein forming the edible soft chew mixture into individual dosage units is performed at no more than 10° C. above room temperature.

14. The process of claim 11 , wherein the bulking agent comprises bran, fiber, fruits, grains, legumes, vegetables, or seeds.

15. A process of claim 6 , further comprising the step of preparing a trituration of the active ingredient with the starch before the active ingredient is added to the remaining dry inactive ingredients.

16. The process of claim 6 , wherein:

(a) the mixing chamber is generally horizontally disposed and comprises a space therein defined by walls to receive material to be mixed;

(b) the mixing shaft extends longitudinally through the chamber space; and

(c) a drive apparatus is operably coupled to the mixing shaft for rotating the shaft.

17. The process of claim 6 , wherein no water is added to the active ingredient.

18. The process of claim 12 , wherein no water is used as an ingredient of the soft chews.

19. The process of claim 6 , wherein forming is conducted by knockout method.

20. The process of claim 6 , wherein forming is conducted without application of compression heat thereto.

Assignments (7)
ASSIGNMENT OF SECURITY INTEREST IN PATENT RIGHTS, RECORDED ON OCTOBER 29, 2020, AT REEL/FRAME 054217/0148 Recorded Dec 3, 2025
From: GOLDMAN SACHS BANK USA, AS RETIRING COLLATERAL AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 073816/0043 →
SECURITY INTEREST Recorded Oct 29, 2020
From: ELANCO US INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 054217/0148 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2020
From: BAYER HEALTHCARE LLC
To: ELANCO US INC.
Reel/Frame 054023/0286 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2015
From: BAYER B.V.
To: BAYER HEALTHCARE, LLC
Reel/Frame 035637/0794 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2015
From: PAULSEN, NEIL E.; JOHNSON, ROLAND; COFFEE, MICHAEL
To: TRIAD SPECIALTY PRODUCTS, LLC
Reel/Frame 035637/0589 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2015
From: TRIAD SPECIALTY PRODUCTS LLC
To: PIEDMONT PHARMACEUTICALS LLC
Reel/Frame 035637/0655 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2015
From: PIEDMONT PHARMACEUTICALS LLC
To: BAYER B.V.
Reel/Frame 035637/0723 →